4.7 Article

Correlates of COVID-19 Vaccine Acceptance and Hesitancy in Rural Communities in Western Kenya

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

A survey of COVID-19 vaccine acceptance across 23 countries in 2022

Jeffrey V. Lazarus et al.

Summary: Despite the availability of safe and effective vaccines, SARS-CoV-2 continued to mutate and spread in 2022. Vaccine hesitancy remains a significant issue, fueled by misinformation. A survey conducted in 23 countries found that 79.1% of respondents were willing to accept vaccination, with an increase from June 2021. However, hesitancy increased in eight countries, ranging from 1.0% to 21.1%. The study also revealed a decrease in support for vaccination mandates and an increase in the use of medications for COVID-19 symptoms.

NATURE MEDICINE (2023)

Article Public, Environmental & Occupational Health

Predictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study

Guy Rodrigue Takoudjou Dzomo et al.

Summary: Vaccination against COVID-19 is crucial in combating the pandemic, but hesitancy and vaccine rejection pose challenges. This study conducted a survey in Chad, interviewing 5,174 participants to understand their perception of COVID-19 vaccines. Findings showed that 47.9% were willing to be vaccinated, 29.8% were undecided, and 22.3% would not accept the vaccine. Urban residents were more hesitant, driven by distrust and misinformation. Lack of knowledge was associated with hesitancy, while acceptance correlated with fear of the disease. Population profiles were identified to aid in strategies against vaccine resistance.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Immunology

Unmet need for COVID-19 vaccination coverage in Kenya

Samuel K. Muchiri et al.

Summary: Understanding the spatial inequalities in COVID-19 vaccination coverage and access to vaccination centers is crucial for national planning of vaccination interventions. This study used data from Kenya to assess vaccination coverage, modeling physical access and using a Bayesian conditional autoregressive model to estimate coverage rates. The findings reveal geographic inequalities at a sub-national level, highlighting the need to target and improve vaccination coverage for hard-to-reach populations.

VACCINE (2022)

Editorial Material Public, Environmental & Occupational Health

COVID-19 vaccine hesitancy in Africa: a call to action

Polydor Ngoy Mutombo et al.

LANCET GLOBAL HEALTH (2022)

Article Medicine, General & Internal

The COVID-19 pandemic in the African continent

Godfrey Bwire et al.

Summary: This passage introduces the discovery of a new coronavirus and the associated COVID-19 disease in China in December 2019. It explains that scientists initially predicted a severe situation in Africa, but the reality did not match the predictions. Therefore, the purpose of this forum is to bring together experts to discuss the current situation of COVID-19 in Africa, analyze why Africa's situation differs from the predictions, and propose measures to support Africa in overcoming the negative effects of COVID-19 and accelerate the achievement of sustainable development goals.

BMC MEDICINE (2022)

Article Immunology

Perceptions and Knowledge towards COVID-19 Vaccine Hesitancy among a Subpopulation of Adults in Kenya: An English Survey at Six Healthcare Facilities

Jasmit Shah et al.

Summary: Vaccine hesitancy in Kenya, although lower than in other countries, remains a dynamic problem. Participants from private facilities have a higher perception of vaccine safety compared to those from faith-based and government facilities.

VACCINES (2022)

Review Public, Environmental & Occupational Health

Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications

Andrew T. Levin et al.

Summary: This study systematically reviewed COVID-19 serology studies in developing countries and found that seroprevalence among older adults was similar to that of younger age cohorts, but age-specific infection fatality rates (IFRs) were approximately twice as high as in high-income countries. The burden of COVID-19 is higher in developing countries due to increased transmission among middle-aged and older adults and limited access to adequate healthcare.

BMJ GLOBAL HEALTH (2022)

Review Medicine, General & Internal

Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review

Michael J. Deml et al.

Summary: This scoping review identified, described, and mapped the research tools used to measure COVID-19 vaccine hesitancy, refusal, acceptance, and access in sub-Saharan Africa (SSA). The findings revealed that while all studies measured COVID-19 vaccine hesitancy, acceptance, and refusal, relatively few studies explicitly measured access to COVID-19 vaccination. Therefore, future research should prioritize the inclusion of access-related variables, and the development of standardized research tools to operationalize and measure the complex determinants of vaccine uptake in SSA and other low- and middle-income country settings is recommended.

BMJ OPEN (2022)

Article Immunology

Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future

Olayinka O. Ogunleye et al.

Summary: The introduction of effective COVID-19 vaccines in December 2020 was a significant step forward in the global response to the pandemic. This exploratory study investigates the current status of vaccine uptake, challenges, and lessons learnt across 14 African countries. The study found variations in vaccine coverage, with low rates in some countries and increased hesitancy due to misinformation. Governments need to address vaccine hesitancy through targeted interventions among healthcare workers, journalists, and the public.

VACCINES (2022)

Article Pediatrics

Vaccine Hesitancy: Obstacles and Challenges

Preeti M. Galagali et al.

Summary: This passage highlights the factors affecting vaccine hesitancy, the role of vaccine hesitancy in limiting vaccine uptake and inability to achieve collective immunity, and possible solutions.

CURRENT PEDIATRICS REPORTS (2022)

Review Public, Environmental & Occupational Health

COVID-19 vaccine hesitancy in Africa: a scoping review

Betty B. B. Ackah et al.

Summary: This study summarized the literature on COVID-19 vaccine hesitancy in Africa, finding fluctuating vaccine acceptance rates in African countries and identifying major reasons for hesitancy including concerns about vaccine safety, lack of trust in the pharmaceutical industry, and conflicting information from the media.

GLOBAL HEALTH RESEARCH AND POLICY (2022)

Review Public, Environmental & Occupational Health

Factors Influencing COVID-19 Vaccine Acceptance in High Income Countries Prior to Vaccine Approval and Rollout: A Narrative Review

Maryke S. Steffens et al.

Summary: This narrative review summarizes the factors influencing acceptance of COVID-19 vaccines prior to their rollout. Findings indicate that trust in health authorities and vaccine stakeholders, confidence in vaccine safety and effectiveness, and a high perception of COVID-19 disease risk are facilitators of acceptance. Barriers include safety and effectiveness concerns, perceived scientific uncertainty, low disease risk perception, and low trust in authorities and other stakeholders.

INTERNATIONAL JOURNAL OF PUBLIC HEALTH (2022)

Editorial Material Pediatrics

Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response

Sunil Bhopal et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Article Immunology

Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada

Britt McKinnon et al.

Summary: This study identified significant social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents. Efforts are needed to develop tailored strategies to promote informed decision making and facilitate vaccination access for disadvantaged and marginalized populations.

VACCINE (2021)

Article Public, Environmental & Occupational Health

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

Michael Schwarzinger et al.

Summary: This study highlights that COVID-19 vaccine acceptance is influenced by the characteristics of new vaccines and national vaccination strategies, as well as factors such as gender, age, education level, and past vaccination history. In the working-age population in France, the outright vaccine refusal rate is approximately 29.4%, while vaccine hesitancy is influenced by vaccine characteristics and information on herd immunity benefits.

LANCET PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Acceptance of COVID-19 vaccines in sub-Saharan Africa: evidence from six national phone surveys

Shelton Kanyanda et al.

Summary: The study estimated the willingness to accept a COVID-19 vaccine in six sub-Saharan African countries and found generally high acceptance rates, ranging from nearly universal in Ethiopia to below herd immunity levels in Mali. Vaccine hesitancy was not significantly correlated with sex or age, but some clusters of hesitancy were observed in urban areas, among the better educated, and in richer households. Safety concerns and side effects were primary reservations toward COVID-19 vaccine acceptance across countries.

BMJ OPEN (2021)

Review Public, Environmental & Occupational Health

A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries

Sandeep Moola et al.

Summary: Vaccine acceptance rates vary across Low- and Middle-Income Countries, with reasons for vaccine hesitancy differing. Factors associated with higher vaccine acceptance include being male, having higher education, higher socio-economic status, being unmarried, and working as a health care worker.

JOURNAL OF GLOBAL HEALTH (2021)

Review Immunology

A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants

Md Rafiul Biswas et al.

Summary: The determinants of worldwide COVID-19 vaccine hesitancy are complex and context-specific, influenced by factors such as vaccine efficacy, side effects, and trust. Vaccination intentions are also impacted by demographic factors, with varying vaccine uptake rates in different countries. Strategies tailored to cultures and socio-psychological factors are needed to reduce vaccine hesitancy and aid informed decision-making.

VACCINES (2021)

Article Medicine, General & Internal

Fake news and fallacies: Exploring vaccine hesitancy in South Africa

Avania Bangalee et al.

Summary: Historically, vaccine hesitancy has posed challenges for public health in combating infectious diseases. In the context of the COVID-19 pandemic, this issue is exacerbated, with South African surveys revealing the complex factors at play. Despite negative press on social media, addressing and understanding vaccine hesitancy is crucial for achieving herd immunity.

SOUTH AFRICAN FAMILY PRACTICE (2021)

Article Immunology

COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study

Dalia Almaghaslah et al.

Summary: The study investigated vaccine hesitancy among young adult population in Saudi Arabia during the COVID-19 pandemic. It found that a significant number of participants are reluctant to receive the vaccine due to concerns about its efficacy and safety, even with a high likelihood of getting the infection.

VACCINES (2021)

Article Public, Environmental & Occupational Health

COVID-19 vaccine acceptance in older Syrian refugees: Preliminary findings from an ongoing study

Noura Salibi et al.

Summary: This study found that a significant portion of Syrian refugees in Lebanon have intentions to refuse the COVID-19 vaccine, with reasons including the novelty of the vaccine and a preference to maintain precautionary measures. Vaccine refusal was significantly associated with perceptions of vaccine safety and effectiveness among respondents.

PREVENTIVE MEDICINE REPORTS (2021)

Article Biochemistry & Molecular Biology

COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

Julio S. Solis Arce et al.

Summary: The acceptance of COVID-19 vaccines in LMICs is higher compared to the United States and Russia, with a focus on personal protection and concerns about side effects. Healthcare workers are the most trusted sources of guidance in LMICs for COVID-19 vaccines, suggesting that prioritizing vaccine distribution to these countries could help advance global immunization coverage.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys

John R. Kerr et al.

Summary: In a series of online surveys between March and October 2020, the willingness to receive a COVID-19 vaccine was studied in relation to sex, trust in experts, and worry about the virus. Results showed that female participants were less willing to accept the vaccine, while trust in medical and scientific experts, as well as worry about the virus, were the strongest correlates of vaccine acceptance.

BMJ OPEN (2021)

Article Biotechnology & Applied Microbiology

COVID-19 vaccine hesitancy: a survey in a population highly compliant to common vaccinations

Flora Fedele et al.

Summary: The survey revealed that only 26.5% of respondents were willing to receive the COVID-19 vaccine, with safety concerns being the main factor for vaccine refusal. Factors such as female gender, younger age, and lower education level were associated with lower vaccine acceptability.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Review Immunology

COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries

Junjie Aw et al.

Summary: This review summarizes rates of COVID-19 vaccine hesitancy and its determinants in high-income countries or regions, indicating that factors such as younger age, female gender, lower education level, and concerns about vaccine safety/efficacy are associated with increased vaccine hesitancy. Policy makers can use these findings to formulate health policies related to COVID-19 vaccination.

VACCINES (2021)

Article Immunology

COVID-19 Vaccine Hesitancy in a Representative Education Sector Population in Qatar

Reem Al-Mulla et al.

Summary: Despite vaccination programs being implemented globally and in Qatar, vaccine hesitancy continues to be a barrier in effectively controlling the pandemic. Factors such as safety, efficacy, and side effects influence willingness to receive the vaccine. A study on Qatar University employees and students found that the majority were willing to receive the COVID-19 vaccine, with postgraduate degree holders showing higher acceptance rates. Males also showed higher vaccine acceptance rates, while concerns about side effects and mandatory vaccination for international travel were noted.

VACCINES (2021)

Review Public, Environmental & Occupational Health

Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review

Ashish Joshi et al.

Summary: The study found that global COVID-19 vaccine acceptance rates vary significantly, with high fluctuations in vaccine hesitancy rates. Factors such as gender, age, education, and trust can influence COVID-19 vaccine acceptance, and tailored interventions are needed to improve vaccine coverage.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Health Policy & Services

COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment

Jagdish Khubchandani et al.

Summary: The study found that 53% of American adults reported being very likely or somewhat likely to get a COVID-19 vaccine, while a significant proportion expressed hesitancy. Lower education level, lower income, and perception of lower risk of infection were associated with higher likelihood of vaccine hesitancy.

JOURNAL OF COMMUNITY HEALTH (2021)

Editorial Material Medicine, General & Internal

Ensuring global access to COVID-19 vaccines

Gavin Yamey et al.

LANCET (2020)

Article Public, Environmental & Occupational Health

'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic

Serena Barello et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Article Public, Environmental & Occupational Health

Vaccine hesitancy: the next challenge in the fight against COVID-19

Amiel A. Dror et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Article Public, Environmental & Occupational Health

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Harapan Harapan et al.

FRONTIERS IN PUBLIC HEALTH (2020)

Article Medicine, General & Internal

Attitudes Toward a Potential SARS-CoV-2 Vaccine A Survey of US Adults

Kimberly A. Fisher et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Biotechnology & Applied Microbiology

The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay

Li Ping Wong et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Article Multidisciplinary Sciences

Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey

Yogambigai Rajamoorthy et al.

PLOS ONE (2019)

Article Immunology

Exploring parents' reasons for incomplete childhood immunisation in Indonesia

Agung Taufiqur Rokhman Syiroj et al.

VACCINE (2019)

Article Biotechnology & Applied Microbiology

Vaccine hesitancy - a potential threat to the achievements of vaccination programmes in Africa

Sara Cooper et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Article Immunology

Vaccine hesitancy: Definition, scope and determinants

Noni E. MacDonald

VACCINE (2015)

Article Biotechnology & Applied Microbiology

Community awareness, use and preference for pandemic influenza vaccines in Pune, India

Neisha Sundaram et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Review Biology

The contribution of vaccination to global health: past, present and future

Brian Greenwood

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)

Review Immunology

Vaccines: the Fourth Century

Stanley A. Plotkin

CLINICAL AND VACCINE IMMUNOLOGY (2009)